

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1278, 2001-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




AR-623 shows efficacy in acute promyelocytic leukaemia
Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. :


Midostaurin shows activity in AML
Inpharma, Vol. 1, Iss. 1479, 2005-01 ,pp. :


Gefitinib shows activity in recurrent glioblastoma
Inpharma, Vol. 1, Iss. 1416, 2003-01 ,pp. :


Fosmidomycin shows promising antimalarial activity
Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. :